Trial NCT02122185

View at ClinicalTrials.gov 
Org. Study IDs: IRB13-1235
Secondary IDs: IRB13-1235 NCI-2014-00860

Last trial update was posted on 2023-08-28

MeSH Interventions

Metformin

MeSH Conditions

Adenocarcinoma Ascites Brenner Tumor Carcinoma Carcinoma, Endometrioid Carcinoma, Ovarian Epithelial Cystadenocarcinoma Cystadenocarcinoma, Serous Fallopian Tube Neoplasms Germinoma Neoplasms, Germ Cell and Embryonal Ovarian Neoplasms Peritoneal Neoplasms Pleural Effusion Pleural Effusion, Malignant Recurrence

Other Conditions

Malignant Ascites Malignant Pleural Effusion Ovarian Clear Cell Cystadenocarcinoma Ovarian Endometrioid Adenocarcinoma Ovarian Mixed Epithelial Carcinoma Ovarian Serous Cystadenocarcinoma Ovarian Undifferentiated Adenocarcinoma Recurrent Fallopian Tube Cancer Recurrent Ovarian Epithelial Cancer Recurrent Ovarian Germ Cell Tumor Recurrent Primary Peritoneal Cavity Cancer Stage IIIA Fallopian Tube Cancer Stage IIIA Ovarian Epithelial Cancer Stage IIIA Ovarian Germ Cell Tumor Stage IIIA Primary Peritoneal Cavity Cancer Stage IIIB Fallopian Tube Cancer Stage IIIB Ovarian Epithelial Cancer Stage IIIB Ovarian Germ Cell Tumor Stage IIIB Primary Peritoneal Cavity Cancer Stage IIIC Fallopian Tube Cancer Stage IIIC Ovarian Epithelial Cancer Stage IIIC Ovarian Germ Cell Tumor Stage IIIC Primary Peritoneal Cavity Cancer Stage IV Fallopian Tube Cancer Stage IV Ovarian Epithelial Cancer Stage IV Ovarian Germ Cell Tumor Stage IV Primary Peritoneal Cavity Cancer

Stopping Reasons

Enrollment halted for planned interim analysis.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID